Zag Bio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeZag Bio
Zag Bio logo

Zag Bio

0 followers

About Zag Bio

Zag Bio is a biotechnology company developing thymus‑targeted therapies to induce T‑cell central tolerance and treat autoimmune diseases. Their platform uses bifunctional antibodies that deliver self‑antigens to antigen‑presenting cells in the thymus, training immune cells to recognize and protect the body’s own tissues, with pipelines that include programs such as ZAG‑101 for type 1 diabetes.

Recent News

No recent news for this company.

Recent Deals

Key Facts

HQ Location

Cambridge, United States

Employees

Unknown

Status

Private

Website

https://zagbio.com